Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,351 people get NVAX articles and Market Currents by email alert.
Get email alerts on NVAX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 7, 2013)
-
-
-
GlobeNewswire (Apr 26, 2013)
-
GlobeNewswire (Apr 25, 2013)
-
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
-
-
-
-
-
GlobeNewswire (Mar 18, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
Novavax Advances Avian Flu Vaccine Despite Government SnubH.S. Ayoub • Wed, Jan 24, 2007 -
Novavax Should Jump On Avian Flu ResultsMicrocap Speculator • Tue, Jan 23, 2007 -
Smallcap Novavax Has Turned a CornerMicrocap Speculator • Tue, Dec 5, 2006
-
Novavax Stuck in DowntrendMicrocap Speculator • Mon, Jul 24, 2006
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Analyzing Wednesday's Noteworthy Insider TradesGuruFundPicks • Thu, Apr 12, 2012
-
-
-
-
Novavax's CEO Discusses Q3 2012 Results - Earnings Call TranscriptFri, Nov 2, 2012
-
Novavax, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 10, 2008
-
Novavax, Inc. Q2 2008 Earnings Call TranscriptTue, Sep 2, 2008
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (Apr 26, 2013)
-
GlobeNewswire (Apr 25, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
GlobeNewswire (Mar 18, 2013)
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Mar 8, 2013)
-
GlobeNewswire (Mar 1, 2013)
-
GlobeNewswire (Feb 22, 2013)
-
GlobeNewswire (Feb 7, 2013)
-
GlobeNewswire (Jan 24, 2013)
-
GlobeNewswire (Dec 6, 2012)
-
GlobeNewswire (Dec 3, 2012)
-
GlobeNewswire (Nov 20, 2012)
-
GlobeNewswire (Nov 12, 2012)
-
GlobeNewswire (Nov 2, 2012)
-
GlobeNewswire (Oct 26, 2012)
NVAX vs. ETF Alternatives
Company Description
Novavax, Inc., a Delaware corporation (“Novavax” or the “Company”), was incorporated in 1987, and is a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. These... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, November 2, 2012, 12:05 AM Notable earnings before Friday’s open: ALU, ANR, ARCO, BEAM, BGCP, BPL, BPO, CTB, CVX, DNDN, FIG, HES, HUN, ITT, MHP, NI, NRF, NRG, NVAX, NVE, RL, SEE, SSYS, TRI, VIAB, VRX, WCRX, XEC, YRCW Comment! [Earnings]
- Thursday, November 1, 2012, 5:30 PM Notable earnings before Friday’s open: ALU, ANR, ARCO, BEAM, BGCP, BPL, BPO, CTB, CVX, DNDN, FIG, HES, HUN, ITT, MHP, NI, NRF, NRG, NVAX, NVE, RL, SEE, SSYS, TRI, VIAB, VRX, WCRX, XEC, YRCW Comment! [Earnings]
- Thursday, October 18, 2012, 11:52 AM Novavax (NVAX +3.5%) gains after saying that Phase I clinical studies of it's investigational avian influenza vaccine met their primary objectives of safety and immune response. Comment! [Healthcare, On the Move]
-
Thursday, October 18, 2012, 9:10 AM
Premarket gainers: GIVN +13%. WCC +11%. SVU +9%. JNPR +7%. NVAX +7%. MGM +6%. AEGR +5%.
Losers: MNKD -25%. CYTR -20%. ALGN -20%. IMUC -18%. LXRX -16%. MLNX -15%. GORO -14%. CDR -7%. SCSS -7%. VRNG -6%. 1 Comment [On the Move] - Friday, August 3, 2012, 8:12 AM Novavax (NVAX): Q2 EPS of -$0.05 beats by $0.02. Revenue of $7.1M (+137% Y/Y) beats by $0.2M. (PR) Comment! [Earnings, Healthcare]
- Friday, August 3, 2012, 12:05 AM Notable earnings before Friday’s open: BPL, BPO, BZH, ELT, HNT, IMGN, ITT, NVAX, NYX, PG, WCG, WCRX, YRCW Comment! [Earnings]
- Thursday, August 2, 2012, 5:30 PM Notable earnings before Friday’s open: BPL, BPO, BZH, ELT, HNT, IMGN, ITT, NVAX, NYX, PG, WCG, WCRX, YRCW Comment! [Earnings]
- Thursday, July 5, 2012, 10:07 AM Novavax (NVAX) provides a positive report from the Phase I trial of what would be the first vaccine for respiratory syncytial virus (RSV), which causes pneumonia, as well as bronchiolitis in babies. Shares -3.5% but they've been rising since the middle of June. (PR) Comment! [Healthcare, On the Move]
- Friday, May 4, 2012, 8:28 AM Novavax (NVAX): Q1 EPS of -$0.06 misses by $0.02. Revenue of $4.64M (+475% Y/Y) beats by $0.2M. Shares +6.7% premarket. (PR) 1 Comment [Earnings, Healthcare, On the Move]
- Friday, March 9, 2012, 8:09 AM Novavax (NVAX): Q4 EPS of -$0.03 beats by $0.01. Revenue of $5.85M misses by $1M. Shares +3.8% premarket. (PR) Comment! [Earnings, Healthcare, On the Move]
- Monday, January 23, 2012, 12:15 PM Shares of vaccine maker Novavax (NVAX +5.4%) surge as nine people die from an outbreak of swine flu in Mexico, with the number of cases almost doubling in a week. Earlier this month, 12 American citizens were reported as infected with H1N1 flu, with fears that the virus had mutated to H3N2v - the strain transmitted from human-to-human. Comment! [Healthcare, On the Move]
- Wednesday, October 5, 2011, 1:39 PM Bio-pharmaceutical developer Novavax (NVAX +4%) trades higher after winning a $1.3M contract from the U.S. Department of Homeland Security to develop a virus-like particle vaccine countermeasure to protect against foot-and-mouth disease. Comment! [Healthcare, On the Move]
- Thursday, September 8, 2011, 3:41 PM Novavax (NVAX +2.8%) gains after an article published in the Journal of Virology says results from a Phase I/II clinical study of the company's H5N1 influenza vaccine candidate conducted in 2008 were largely successful. Comment! [Healthcare, On the Move]
- Tuesday, August 30, 2011, 2:58 PM Shares of vaccine maker Novavax (NVAX +13.7%) jump after the United Nations reports of a resurgence in bird flu cases in Asia, Europe and the Middle East. 1 Comment [Healthcare, On the Move]
-
Tuesday, April 5, 2011, 9:00 AM
Premarket gainers: NSM +71%. CBST +15%. QCOR +14%. RTK +13%. DMND +9%. EXPE +5%. ONNN +5%. VHC +5%. SSN +4%. NVAX +3%. PSTI +3%. GOLD +3%. CIEN +3%. CTRP +3%.
Losers: LEDS -23%. KBH -9%. KYN -5%. CREE -5%. IRE -6%. PSEC -5%. TGP -5%. AVL -3%. AIB -3%. HMC -3%. Comment! -
Thursday, March 3, 2011, 9:00 AM
Premarket gainers: GTEC +51%. BPAZ +15%. ZAGG +9%. ITMN +5%. LCC +5%. JK +5%. NVO +5%. KR +4%. SOL +4%. PWER +4%. KEY +4%. LDK +4%. RCL +4%. SSN +4%. SHZ +3%. ERIC +3%. JASO +3%. NBG +3%. YGE +3%. CRH +3%. STP +3%. PCX +3%. DPTR +3%. AMR +3%. ASML +3%. PMI +3%. BUD +3%. JDSU +3%. NVAX +3%.
Losers: AMLN -26%. ALKS -15%. FSYS -14%. SIMG -6%. GMXR -5%. Comment!
-
Michael Webb
$NVAX Something big is happening at Novavax: in addition to their break through technology and best management practices. - View all 0 replies
-
- View all 0 replies
-
Michael Webb
$NVAX Stanley Erck presents at Piper J the same thread of thought regarding world-wide facility creation found in my article. So proud! - View all 0 replies
-
- View all 1 replies
-
Michael Webb: Hey Bull! It's been so good I've been thinking about taking some profits. You?
-
- View all 2 replies
-
-
-
- View all 1 replies
-
-
Jim Van Meerten
NVAX - 96% Barchart technical buy signal - 14 new highs and up 38.46% in the last month - Relative Strength Index 65.60% - View all 0 replies
-
Jim Van Meerten
NVAX - 96% Barchart technical buy signal - 19 new highs and up 69.29% in the alst month - Relative Strength Index 89.03% - View all 2 replies
-
-
-
- View all 0 replies
-
Jim Van Meerten
NVAX - 96% Barchart technical buy signal - 19 new highs and up 68.03% in the last month - Relative Strength Index 88.31% - View all 0 replies
LATEST REPLIES